At a glance
- Originator Eli Lilly and Company
- Class Analgesics; Anti-inflammatories; Antirheumatics; Indoles; Small molecules
- Mechanism of Action Phospholipase A2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Adult respiratory distress syndrome; Inflammation; Systemic inflammatory response syndrome
Most Recent Events
- 23 Mar 2000 No-Development-Reported for Inflammation (Unknown route)
- 23 Mar 2000 No-Development-Reported for Systemic inflammatory response syndrome (IV)
- 01 Oct 1998 Preclinical development for Adult respiratory distress syndrome in France (Unknown route)